Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs MOREPEN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA MOREPEN LABS NATCO PHARMA/
MOREPEN LABS
 
P/E (TTM) x 12.7 30.4 41.6% View Chart
P/BV x 4.2 4.7 88.8% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 NATCO PHARMA   MOREPEN LABS
EQUITY SHARE DATA
    NATCO PHARMA
Mar-24
MOREPEN LABS
Mar-24
NATCO PHARMA/
MOREPEN LABS
5-Yr Chart
Click to enlarge
High Rs1,10856 1,966.0%   
Low Rs55025 2,172.3%   
Sales per share (Unadj.) Rs223.333.1 675.1%  
Earnings per share (Unadj.) Rs77.51.9 4,100.7%  
Cash flow per share (Unadj.) Rs87.92.5 3,455.5%  
Dividends per share (Unadj.) Rs9.500-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs326.816.6 1,971.7%  
Shares outstanding (eoy) m179.11511.17 35.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.71.2 300.7%   
Avg P/E ratio x10.721.6 49.5%  
P/CF ratio (eoy) x9.416.0 58.7%  
Price / Book Value ratio x2.52.5 103.0%  
Dividend payout %12.30-   
Avg Mkt Cap Rs m148,50920,879 711.3%   
No. of employees `000NANA-   
Total wages/salary Rs m5,2501,815 289.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m39,98816,904 236.6%  
Other income Rs m1,281140 916.9%   
Total revenues Rs m41,26917,044 242.1%   
Gross profit Rs m17,5141,586 1,104.1%  
Depreciation Rs m1,868335 558.1%   
Interest Rs m19237 517.5%   
Profit before tax Rs m16,7351,354 1,235.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,852388 735.1%   
Profit after tax Rs m13,883966 1,436.9%  
Gross profit margin %43.89.4 466.7%  
Effective tax rate %17.028.6 59.5%   
Net profit margin %34.75.7 607.4%  
BALANCE SHEET DATA
Current assets Rs m40,2358,890 452.6%   
Current liabilities Rs m9,7284,020 242.0%   
Net working cap to sales %76.328.8 264.8%  
Current ratio x4.12.2 187.0%  
Inventory Days Days6216 396.5%  
Debtors Days Days109702 15.5%  
Net fixed assets Rs m28,6344,042 708.5%   
Share capital Rs m3581,022 35.0%   
"Free" reserves Rs m58,1737,450 780.8%   
Net worth Rs m58,5318,472 690.9%   
Long term debt Rs m034 0.0%   
Total assets Rs m68,86912,932 532.5%  
Interest coverage x88.237.5 235.1%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.61.3 44.4%   
Return on assets %20.47.8 263.4%  
Return on equity %23.711.4 208.0%  
Return on capital %28.916.4 176.8%  
Exports to sales %037.8 0.0%   
Imports to sales %9.532.0 29.7%   
Exports (fob) Rs mNA6,388 0.0%   
Imports (cif) Rs m3,7985,405 70.3%   
Fx inflow Rs m27,3476,388 428.1%   
Fx outflow Rs m3,7985,584 68.0%   
Net fx Rs m23,549803 2,931.8%   
CASH FLOW
From Operations Rs m12,116734 1,651.2%  
From Investments Rs m-10,327-833 1,239.7%  
From Financial Activity Rs m-2,46952 -4,743.5%  
Net Cashflow Rs m-615-47 1,302.7%  

Share Holding

Indian Promoters % 49.6 35.7 139.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.3 3.8 640.1%  
FIIs % 17.5 2.1 841.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.4 64.4 78.3%  
Shareholders   302,944 430,929 70.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Natco Pharma vs MOREPEN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs MOREPEN LABS Share Price Performance

Period Natco Pharma MOREPEN LABS S&P BSE HEALTHCARE
1-Day 0.61% -3.51% 0.11%
1-Month 0.26% -10.83% -3.22%
1-Year 76.43% 84.13% 42.65%
3-Year CAGR 19.45% 15.71% 19.86%
5-Year CAGR 19.87% 33.91% 25.90%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the MOREPEN LABS share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.6% stake in the company. In case of MOREPEN LABS the stake stands at 35.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of MOREPEN LABS.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 12.3%.

MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of MOREPEN LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.